Results 1 to 10 of about 642,036 (246)

Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist [PDF]

Endocrinology and Metabolism, 2013
Gonadotropin-releasing hormone (GnRH) agonist has been used in the treatment of a wide variety of sex-hormone-related diseases, as the administration of GnRH agonist can alter the secretion of gonadotropin and sex hormones.
Eun Jin Han, Ha Do Song, Ji Hoon Yang, So Young Park, Sung Hoon Kim, Hyun Koo Yoon, Chang Hoon Yim   +6 more
doaj   +2 more sources

Gonadotrophine Releasing Hormone Agonist As A Trigger of Ovulation in poly cystic ovary syndrome [PDF]

Minia Journal of Medical Research, 2021
Gonadotropin-releasing hormone agonist (GnRH-a) has been used to suppress gonadotropins in several conditions including endometriosis, uterine fibroids, central gonadotropin- dependent precocious puberty, where gonadotropin suppression does not occur ...
Ayman Yousef, Hashem Mohamed, Mamdouh Hamdy, Mohamed Mohamed, Emad Abd El-Moaty   +4 more
doaj   +1 more source

Elevated Pre-injection Basal Luteinizing Hormone Concentrations are Common in Girls Treated for Central Precocious Puberty

JCRPE, 2021
Objective:A consensus on how to monitor girls with central precocious puberty (CPP) during gonadotropin-releasing hormone agonist (GnRHa) treatment is lacking.
Stefanie Schubert, Amalie H. Hvelplund, Aase Handberg, Søren Hagstroem, Tina Lund Leunbach   +4 more
doaj   +1 more source

Pregnancy Outcomes of Different Endometrial Preparation in Patients With a History of Cesarean Section

Frontiers in Endocrinology, 2022
ObjectiveTo investigate the efficacies of three cycle regimens in women receiving frozen embryo transfer with a history of cesarean section: natural cycle treatment, hormone replacement therapy and treatment with gonadotropin-releasing hormone agonist ...
Run Xin Gan, Run Xin Gan, Yuan Li, Yuan Li, Juan Song, Quan Wen, Quan Wen, Guang Xiu Lu, Guang Xiu Lu, Ge Lin, Ge Lin, Fei Gong, Fei Gong   +12 more
doaj   +1 more source

pS6K1 as an efficacy marker of GnRH agonist with premenopausal breast cancer

Endocrine Connections, 2019
Estradiol is a key factor for tumorigenesis and prognosis of hormone receptor-positive breast cancer. Adipocytes are one source of estradiol in patients with breast cancer. Recent studies have shown that phosphorylated ribosomal protein S6 kinase-1 plays
Chan Sub Park, Jihye Choi, Min-Ki Seong, Sung-Eun Hong, Jae-Sung Kim, In-Chul Park, Hyesil Seol, Woo Chul Noh, Hyun-Ah Kim   +8 more
doaj   +1 more source

GnRH agonist as a luteal support in IVF cycle: mini-review—is there a role?

Middle East Fertility Society Journal, 2022
Background It has been established that assisted reproductive technology (ART) cycles are usually accompanied by a defective luteal phase, and that luteal phase support (LPS) is mandatory to improve reproductive outcomes.
Hasan Maghraby, Amr S. Abdelbadie, Ashraf Aboali, Aboubakr Elnashar   +3 more
doaj   +1 more source

Choosing trigger of ovulation for optimization of in vitro fertilization programs (literature review) [PDF]

Гинекология, 2016
This review presents recent data on the impact of different triggers on the clinical and embryological indicators of the effectiveness of assisted reproductive technology in patients with normal and excessive ovarian response to superovulation ...
S M Eapen, N G Mishiyeva, B A Martazanova, T V Dontsova, S V Pavlovich   +4 more
doaj  

Effect of luteal phase support gonadotropin-releasing hormone agonist on the endometrial receptivity and outcomes of in vitro fertilization programs [PDF]

Гинекология, 2016
Patients with tubal infertility in implantation window period show impaired endometrial receptivity with low implantation potention that is characterized by decrease in mature pinopodes level on endometrium, decreased expression of leukemia inhibitory ...
E M Savelyeva, S G Perminova, T A Demura, D A Strelchenko   +3 more
doaj  

Gonadotropin-Releasing Hormone Agonists in the Treatment of Prostate Cancer [PDF]

Endocrine Reviews, 2005
In 1979, the first prostate cancer patient was treated with a GnRH agonist at the Laval University Medical Center in Quebec City, Canada, thus rapidly leading to the worldwide replacement of surgical castration and high doses of estrogens. The discovery of medical castration with GnRH agonists was soon followed by fundamental changes in the endocrine ...
Fernand, Labrie, Alain, Bélanger, Van, Luu-The, Claude, Labrie, Jacques, Simard, Leonello, Cusan, José, Gomez, Bernard, Candas   +7 more
openaire   +2 more sources

Final oocyte maturation with a dual trigger compared to human chorionic gonadotropin trigger in antagonist co-treated cycles: A randomized clinical trial

Middle East Fertility Society Journal, 2018
Objective: This clinical trial compared the effect of a dual trigger treatment (combination of gonadotropin-releasing hormone (GnRH) agonist and human chorionic gonadotropin (hCG) and hCG alone on oocyte quality and metaphase II oocytes’ number. Methods:
Ashraf Alleyassin, Marzieh Ghasemi, Marzieh Aghahosseini, Leila Safdarian, Fatemeh Sarvi, Amir Almasi-Hashiani, Sedigheh Hosseinimousa, Aida Najafian, Arezoo Esmailzadeh   +8 more
doaj   +1 more source